beta 2 adrenoreceptor agonists/muscarinic receptor antagonists (Theravance)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namebeta 2 adrenoreceptor agonists/muscarinic receptor antagonists (Theravance)
Drug Alias NameTHRX-494732THRX-198321
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsBeta-2 adrenergic receptor agonists
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoviva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoviva Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A